Albany, New York, October 27, 2016: A new research report has been added to the database of Market Research Hub titled, “Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)”. This research offers an in-depth study on the global market along with markets of the US and Europe. Hepatitis virus infections affect millions of people around the globe. Scientists and medical professionals are focusing on effective treatment methods to treat and manage Hepatitis B disease.
Request a Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=849306
The report starts with the description, causes, symptoms and treatment of the Hepatitis B virus on the human body. Hepatitis B is a virus that leads to the inflammation of the liver. The transmission of HBV widely occurs through infected blood or the use of intrusive medical equipment which is infected with HBV. Adults who suffer from it for a short time period are diagnosed with acute hepatitis B. On the other hand, sometimes the virus causes a long-term infection which is called chronic hepatitis B. As a result, it can damage the liver lead to serious consequences like liver cancer (hepatocellular carcinoma) and liver failure. Babies and young children infected with this virus are more likely to get chronic hepatitis B also. Major symptoms of hepatitis B include abdominal pain, fever, dark urine, and joint pain.
The key factors that are responsible for driving the growth of global hepatitis B virus (HBV) market are rise of liver cancer and cirrhosis deaths, increasing population, growing healthcare expenditure and urbanization. Owing to these factors, many governments in the US and European countries have made it obligatory for the people to go through proper screening and monitoring since hepatitis B takes time to develop and it is not easily detectable.
According to the report, the number of people affected by Hepatitis B virus is over 2 billion. There are some healing therapies available but they are not very effective. It is expected that many innovative therapies which have shown positive outcomes in trials will occupy the market in the given forecast of 2016 to 2025.
The report also offers an overview on the key drivers and trends impacting the market. The industry comprises large companies such as Arrowhead, Gilead, Arbutus, and Johnson & Johnson. All these companies have been outlined in the current report and their key financials and business strategies for growth have been highlighted.
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.